Securities law
Bernard J. Cassidy, Executive Vice President, General Counsel, and Corporate Secretary of Sana Biotechnology, Inc., has announced his planned retirement, effective October 20, 2025. Cassidy's departure is voluntary and for personal reasons, not a result of any disagreement with the company. His successor, Aaron M. Grossman, is expected
Securities law
Aimei Health Technology Co., Ltd., a Cayman Islands-based company, has announced the extension of its initial business combination with United Hydrogen Group Inc. The company has filed a Form 8-K with the U.S. Securities and Exchange Commission, disclosing that it has received an aggregate of $150,000, which enables
Securities law
VSEE Health, Inc., a company listed on the Nasdaq Stock Market, has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission (SEC) on September 5, 2025, indicating that the company's common stock and public warrants will be delisted due to non-compliance with
Securities law
Investors who purchased or otherwise acquired Semler Scientific Inc. ("Semler" or the "Company") securities between March 10, 2021, and April 15, 2025, inclusive, must file a lead plaintiff motion in the class action filed on their behalf by October 28, 2025. The lawsuit alleges that Semler
Securities law
Investors who purchased shares of Cybin Inc. (NYSE: CYBN) may have suffered losses due to allegations of securities fraud. The law firm Pomerantz LLP is investigating claims on behalf of investors, with concerns that the Company and its officers may have engaged in unlawful business practices. This investigation comes after
Class action lawsuits
Investors who were adversely affected by alleged securities fraud in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP between September 27, 2023 and January 27, 2025 may be eligible to recover losses on behalf of the company. The lawsuit seeks to recover losses on behalf of XPLR Infrastructure,
Class action lawsuits
Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP) regarding possible violations of federal securities laws. The company, which serves the pharmaceutical, biotechnology, and chemical industries, acquired Pro-ficiency Holdings, Inc. in June 2024, promoting the integration as a key driver of growth.
Class action lawsuits
Tesla, Inc. (NASDAQ: TSLA) investors who suffered losses between April 19, 2023, and June 22, 2025, may be eligible for a potential recovery under federal securities laws. A class action lawsuit was filed against the company, alleging securities fraud related to the overstated effectiveness of its autonomous driving technology and
Class action lawsuits
A class action securities lawsuit was filed against Capricor Therapeutics, Inc. due to alleged securities fraud between October 9, 2024, and July 10, 2025. The company's lead cell therapy candidate drug deramiocel for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD) was at the center of
Class action lawsuits
Lockheed Martin Corporation is facing a class-action securities lawsuit alleging the company made false statements and concealed significant risks in its contracts, leading to significant losses for shareholders. The lawsuit claims that the company lacked effective internal controls and oversold its ability to deliver on contract commitments. The alleged securities
Stock exchanges
The Eaton Vance Tax-Advantaged Dividend Income Fund, a Massachusetts-based investment company, has announced the appointment of Scott E. Wennerholm as Chairperson of its Board of Trustees. This change comes four days after the passing of the previous Chairperson, with Susan J. Sutherland serving as acting Chairperson since August 9, 2025.
Stock exchanges
Verb Technology Company, Inc., a Nevada-based company, has submitted a Form 8-K filing with the U.S. Securities and Exchange Commission on August 28, 2025. The filing aims to clarify market rumors surrounding the company's financing plans. In a statement, Verb Technology confirmed that, aside from at-the-market offerings
